ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
126.526,27
1,51%
S&P 500
5.099,96
1,02%
US Dollar vs BRL
5,1163
0,00%
Bitcoin
63.242,69
-0,78%
Brent Oil
88,165
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Ardelyx Inc (ARDX)

  7. Ardelyx Inc (ARDX) Notícias

ARDX Ardelyx Inc

6,45
0,14 (2,22%)
26 Abr 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Ardelyx Inc ARDX NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
0,14 2,22% 6,45 20:57:45
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
6,39 6,30 6,59 6,42 6,31
mais cotações »

Notícias Recentes

Data Hora Fonte Título
18/04/202409:00GLOBEArdelyx to Report First Quarter 2024 Financial Results on..
28/03/202417:05GLOBEArdelyx, Inc. Reports Employment Inducement Grants
25/03/202409:00GLOBEArdelyx Appoints Veteran BioPharma Executive, Mike Kelliher,..
12/03/202417:35GLOBEArdelyx, Inc. Reports Employment Inducement Grants
27/02/202410:00GLOBEArdelyx to Participate at the Cowen 44th Annual Health Care..
22/02/202418:01GLOBEArdelyx Reports Fourth Quarter and Full Year 2023 Financial..
22/02/202408:05IHMARKETNEWSU.S. Futures Surge on Nvidia’s Stellar Performance, Global..
01/02/202410:00GLOBEArdelyx to Report Fourth Quarter and Full Year 2023..
12/01/202409:56GLOBEArdelyx, Inc. Reports Employment Inducement Grants
08/01/202410:00GLOBEArdelyx Provides Update on Growing Commercial Momentum and..
03/01/202410:03GLOBEArdelyx to Provide Company Update on IBSRELA® and Host a KOL..
20/12/202310:00GLOBEArdelyx, Inc. Reports Employment Inducement Grants
21/11/202318:02GLOBEArdelyx, Inc. Reports Employment Inducement Grants
21/11/202310:01GLOBEArdelyx to Participate at the Piper Sandler 35th Annual..
15/11/202318:02GLOBEXPHOZAH® (tenapanor) Granted Orphan Drug Designation by U.S...
13/11/202318:02GLOBEArdelyx Announces Departure of Board Member
10/11/202310:05GLOBEArdelyx to Participate at the Jefferies London Healthcare..
06/11/202310:00GLOBEArdelyx Announces XPHOZAH® (tenapanor) Now Available in the..
03/11/202309:00GLOBEArdelyx Shares Positive Data from Studies of XPHOZAH®..
31/10/202308:00GLOBEArdelyx Reports Third Quarter 2023 Financial Results and..
30/10/202318:42GLOBEArdelyx, Inc. Reports Employment Inducement Grants
23/10/202309:07GLOBEArdelyx Shares Positive Data on Symptom Response During..
18/10/202317:02GLOBEArdelyx to Report Third Quarter 2023 Financial Results on..
18/10/202316:35APSBiotech Finds Mid-Week Success Following FDA Announcement
18/10/202310:03IHMARKETNEWSWednesday’s Wall Street Highlights: ASML, Nvidia, United..
18/10/202309:30DJNArdelyx Shares Rally Premarket on FDA Approval of Xphozah
17/10/202320:44DJNArdelyx Gets FDA OK for Add-On Therapy for Kidney Disease..
17/10/202320:23GLOBEArdelyx Announces Amendment of Debt Financing Agreement with..
17/10/202320:01GLOBEFDA Approves XPHOZAH® (tenapanor), a First-in-Class..
13/10/202309:00GLOBEArdelyx to Present Data Updates for XPHOZAH (tenapanor) for..
04/10/202309:00GLOBEArdelyx Shares Preliminary Data on Use of IBSRELA®..
28/09/202309:02GLOBEArdelyx Announces Publication of Positive Results from..
25/09/202305:15GLOBETenapanor for Hyperphosphatemia Approved in Japan
11/09/202309:00GLOBEArdelyx Showcased Encouraging Data on Treatment Satisfaction..
08/09/202309:00GLOBEArdelyx to Present at the H.C. Wainwright 25th Annual Global..
07/09/202309:00GLOBEArdelyx, Inc. Reports Employment Inducement Grants
02/08/202308:00GLOBEArdelyx Reports Second Quarter 2023 Financial Results and..
27/07/202317:05GLOBEArdelyx, Inc. Reports Employment Inducement Grants
26/07/202308:55GLOBEArdelyx to Report Second Quarter 2023 Financial Results on..
20/07/202317:05GLOBEArdelyx to Present at the H.C. Wainwright 2nd Annual Kidney..
13/07/202309:00GLOBEArdelyx Announces Acceptance of New Drug Application for..
29/06/202317:09GLOBEArdelyx, Inc. Reports Employment Inducement Grants
05/06/202309:00GLOBELeading Proxy Advisory Firms ISS and Glass Lewis Recommend..
31/05/202309:00GLOBEArdelyx to Present at the Jefferies 2023 Healthcare..
23/05/202317:05GLOBEArdelyx, Inc. Reports Employment Inducement Grants
17/05/202308:30GLOBEArdelyx Announces FDA Acceptance and Six-Month Review for..
15/05/202317:05GLOBEArdelyx, Inc. Reports Employment Inducement Grants
09/05/202309:00GLOBEArdelyx Presents Positive Data at DDW 2023 on IBSRELA®..
03/05/202317:02GLOBEArdelyx Reports First Quarter 2023 Financial Results and..
01/05/202309:00GLOBEArdelyx Announces Additional Data Supporting First-In-Class..

Seu Histórico Recente

NASDAQ
ARDX
Ardelyx
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados